INDSWFTLAB · Ind-Swift Laboratories Limited · Financials
Volume · Nov 13
17.78K
Avg daily vol (3M)
60.16K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
6.41B
+14.2%
FY2026
Net Income
0
FY2026
Operating Cash Flow
-631.78M
-148%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|---|---|
| INR | 7.53B | 6.41B | 5.62B | 12.81B | 12.07B | 10.39B | 7.8B |
| INR | 323.06M | 306.06M | 244.79M | 533.03M | 573.62M | 1.31B | 900.59M |
| INR | 2.78M | 14.05M | 29.19M | 511.04M | 921.66M | 955.34M | 1.07B |
| INR | — | — | — | 5.82B | — | 125.33M | -197.71M |
| INR | 180.69M | 77.3M | 72.7M | 1.51B | 386.9M | 146.82M | 14.17M |
| INR | 437.61M | 0 | 0 | 0 | 0 | -21.49M | -211.88M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.